ELDN logo

Eledon Pharmaceuticals (ELDN) Cash From Investing

Annual CFI

-$45.29 M
-$45.29 M-100.00%

December 31, 2023

Summary

Performance

1-Year Change

-100%

3-Year Change

-510.39%

5-Year Change

-

15-Year Change

-294.72%

ELDN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

20.68%
ELDN annual cash flow from investing activities is higher than 20.68% of companies in Healthcare sector

High & Low

All-time High

$23.26 M
ELDN annual cash flow from investing activities is currently -294.72% below its historical high of $23.26 million

3-Year Low

-$45.29 M
ELDN annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ELDN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
ELDN next annual earnings announcement is scheduled for Mar 28, 2025

OtherELDNcash flowmetrics:

Annual CFF

$33.02 M
ELDN annual cash flow from financing activities is $33.02 million

Annual CFO

-$39.53 M
ELDN annual cash flow from operations is -$39.53 million

Annual FCF

-$39.53 M
ELDN annual free cash flow is -$39.53 million

Annual CAPEX

-
ELDN annual capital expenditures value is unknown

Quarterly CFI

-$12.80 M
+$7.11 M+35.71%

September 30, 2024

Summary

Performance

3-Month Change

+35.71%

1-Year Change

+48.85%

3-Year Change

+48.85%

5-Year Change

+48.85%

ELDN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.87%
ELDN quarterly cash flow from investing activities is higher than 21.87% of companies in Healthcare sector

High & Low

All-time High

$23.26 M
ELDN quarterly cash flow from investing activities is currently -155.04% below its historical high of $23.26 million

3-Year Low

-$30.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ELDN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
ELDN next earnings announcement is scheduled for Mar 28, 2025

OtherELDNcash flowmetrics:

Quarterly CFF

$5.28 M
ELDN quarterly cash flow from financing activities is $5.28 million

Quarterly CFO

-$11.77 M
ELDN quarterly cash flow from operations is -$11.77 million

Quarterly FCF

-$11.77 M
ELDN quarterly free cash flow is -$11.77 million

Quarterly CAPEX

-
ELDN quarterly capital expenditures value is unknown

TTM CFI

-$12.86 M
+$12.23 M+48.75%

September 30, 2024

Summary

Performance

3-Month Change

+48.75%

1-Year Change

+76.78%

3-Year Change

+76.78%

5-Year Change

+76.78%

ELDN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.38%
ELDN TTM cash flow from investing activities is higher than 31.38% of companies in Healthcare sector

High & Low

All-time High

$23.27 M
ELDN TTM cash flow from investing activities is currently -155.24% below its historical high of $23.27 million

3-Year Low

-$55.36 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ELDN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
ELDN next earnings announcement is scheduled for Mar 28, 2025

OtherELDNcash flowmetrics:

TTM CFF

$53.35 M
ELDN TTM cash flow from financing activities is $53.35 million

TTM CFO

-$37.41 M
ELDN TTM cash flow from operations is -$37.41 million

TTM FCF

-$37.41 M
ELDN TTM free cash flow is -$37.41 million

TTM CAPEX

-
ELDN TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ELDN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%+48.9%+76.8%
3 y3 years-510.4%+48.9%+76.8%
5 y5 years-+48.9%+76.8%

ELDN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%at low-227.1%+57.8%<-9999.0%+76.8%
5 y5-year-510.4%at low-216.0%+57.8%-216.5%+76.8%
alltimeall time-294.7%at low-155.0%+57.8%-155.2%+76.8%

Eledon Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$12.80 M(-35.7%)
-$12.86 M(-48.7%)
Jun 2024
-
-$19.91 M(-303.5%)
-$25.08 M(-29.4%)
Mar 2024
-
$9.78 M(-2.9%)
-$35.50 M(-21.6%)
Dec 2023
-$45.29 M(<-9900.0%)
$10.08 M(-140.3%)
-$45.29 M(-18.2%)
Sep 2023
-
-$25.03 M(-17.5%)
-$55.36 M(+82.5%)
Jun 2023
-
-$30.33 M(<-9900.0%)
-$30.33 M(<-9900.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2022
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2022
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2022
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2020
$11.04 M(>+9900.0%)
$0.00(-100.0%)
$11.04 M(0.0%)
Sep 2020
-
$11.04 M(>+9900.0%)
$11.04 M(>+9900.0%)
Dec 2019
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2018
-
$0.00(0.0%)
$23.26 M(0.0%)
Dec 2017
$23.26 M
$0.00(0.0%)
$23.26 M(-0.1%)
DateAnnualQuarterlyTTM
Sep 2017
-
$0.00(-100.0%)
$23.27 M(+0.0%)
Jun 2017
-
$23.26 M(>+9900.0%)
$23.27 M(>+9900.0%)
Mar 2017
-
$0.00(-100.0%)
$18.00 K(+1700.0%)
Dec 2016
$1000.00(-100.0%)
$13.00 K(-750.0%)
$1000.00(-100.3%)
Sep 2016
-
-$2000.00(-128.6%)
-$328.00 K(-98.0%)
Jun 2016
-
$7000.00(-141.2%)
-$16.18 M(-60.0%)
Mar 2016
-
-$17.00 K(-94.6%)
-$40.48 M(-0.1%)
Dec 2015
-$40.51 M(>+9900.0%)
-$316.00 K(-98.0%)
-$40.51 M(+0.8%)
Sep 2015
-
-$15.85 M(-34.7%)
-$40.19 M(+64.1%)
Jun 2015
-
-$24.30 M(>+9900.0%)
-$24.50 M(>+9900.0%)
Mar 2015
-
-$45.00 K(<-9900.0%)
-$208.00 K(+18.9%)
Dec 2014
-$175.00 K(+230.2%)
$0.00(-100.0%)
-$175.00 K(0.0%)
Sep 2014
-
-$157.00 K(+2516.7%)
-$175.00 K(+872.2%)
Jun 2014
-
-$6000.00(-50.0%)
-$18.00 K(+50.0%)
Mar 2014
-
-$12.00 K
-$12.00 K
Dec 2013
-$53.00 K(+562.5%)
-
-
Dec 2012
-$8000.00
-
-

FAQ

  • What is Eledon Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Eledon Pharmaceuticals?
  • What is Eledon Pharmaceuticals annual CFI year-on-year change?
  • What is Eledon Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Eledon Pharmaceuticals?
  • What is Eledon Pharmaceuticals quarterly CFI year-on-year change?
  • What is Eledon Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Eledon Pharmaceuticals?
  • What is Eledon Pharmaceuticals TTM CFI year-on-year change?

What is Eledon Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of ELDN is -$45.29 M

What is the all time high annual CFI for Eledon Pharmaceuticals?

Eledon Pharmaceuticals all-time high annual cash flow from investing activities is $23.26 M

What is Eledon Pharmaceuticals annual CFI year-on-year change?

Over the past year, ELDN annual cash flow from investing activities has changed by -$45.29 M (-100.00%)

What is Eledon Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of ELDN is -$12.80 M

What is the all time high quarterly CFI for Eledon Pharmaceuticals?

Eledon Pharmaceuticals all-time high quarterly cash flow from investing activities is $23.26 M

What is Eledon Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, ELDN quarterly cash flow from investing activities has changed by +$12.23 M (+48.85%)

What is Eledon Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of ELDN is -$12.86 M

What is the all time high TTM CFI for Eledon Pharmaceuticals?

Eledon Pharmaceuticals all-time high TTM cash flow from investing activities is $23.27 M

What is Eledon Pharmaceuticals TTM CFI year-on-year change?

Over the past year, ELDN TTM cash flow from investing activities has changed by +$42.51 M (+76.78%)